Byulleten Sibirskoy Meditsiny
Scope & Guideline
Bridging Research and Clinical Practice in Molecular Medicine
Introduction
Aims and Scopes
- Pathophysiological Research:
Investigating the underlying mechanisms of diseases, including metabolic syndromes, cancers, and infectious diseases, to understand their progression and develop targeted therapies. - Clinical Studies and Trials:
Conducting clinical research to assess the effectiveness of treatments, medications, and interventions in various medical conditions, particularly focusing on cardiovascular diseases and metabolic disorders. - Innovative Diagnostic Techniques:
Exploring and validating new diagnostic methods, including imaging techniques and biomarker assessments, to enhance the accuracy and timeliness of disease detection. - Genetic and Molecular Medicine:
Examining the role of genetic factors and molecular pathways in disease susceptibility and progression, contributing to personalized medicine approaches. - Public Health and Epidemiology:
Addressing public health issues, including the impact of lifestyle factors on health outcomes and the prevalence of diseases in specific populations, especially in the context of Siberia. - Translational Medicine:
Bridging laboratory research and clinical application to facilitate the translation of scientific discoveries into effective treatments and health practices.
Trending and Emerging
- COVID-19 Related Research:
There is a significant increase in research focusing on COVID-19, including studies on its long-term effects, treatment strategies, and public health implications, highlighting the pandemic's impact on medical research priorities. - Metabolic Disorders and Obesity:
Research on obesity and its related metabolic disorders is trending, with a focus on understanding the biochemical and genetic factors involved, as well as developing innovative treatment approaches such as bariatric surgery. - Immunotherapy and Personalized Medicine:
Emerging themes include the exploration of immunotherapy and personalized medicine, particularly in oncology, as researchers seek to tailor treatments based on individual genetic profiles and tumor characteristics. - Mental Health and Chronic Diseases:
The intersection of mental health and chronic diseases is gaining traction, addressing the psychological aspects of chronic illness management and the impact of mental health on physical health outcomes. - Innovative Biomarkers and Diagnostics:
There is a growing emphasis on identifying and validating new biomarkers for disease diagnosis and prognosis, particularly in cancer and cardiovascular diseases, to improve early detection and treatment efficacy. - Artificial Intelligence in Medicine:
The integration of artificial intelligence and machine learning in clinical research is on the rise, focusing on predictive analytics and enhancing diagnostic accuracy, particularly in cardiology and oncology.
Declining or Waning
- Traditional Pharmacological Interventions:
There appears to be a waning focus on conventional pharmacological treatments, as research shifts towards novel therapies and integrative approaches that address the underlying causes of diseases rather than just their symptoms. - Basic Laboratory Studies:
The journal seems to be publishing fewer studies that focus solely on basic laboratory experiments without clinical relevance, as there is an increasing emphasis on translational research that connects laboratory findings to clinical applications. - Comorbidities in Isolated Studies:
Research on comorbidities, while still relevant, is becoming less frequent as a standalone focus, suggesting that studies are increasingly integrating comorbid conditions into broader health assessments rather than treating them in isolation. - Epidemiological Studies Without Interventional Focus:
There is a noticeable decline in purely observational epidemiological studies that do not propose interventions or solutions, as the journal emphasizes actionable research that can directly impact clinical practice. - Historical Medical Practices:
Topics centered around historical medical practices or outdated treatment methodologies are becoming less prevalent, reflecting a shift towards contemporary and evidence-based practices in medicine.
Similar Journals
JOURNAL OF MOLECULAR MEDICINE-JMM
Pioneering Insights in Drug Discovery and Genetics.JOURNAL OF MOLECULAR MEDICINE (JMM) is a premier publication dedicated to advancing the field of molecular medicine, encompassing critical areas such as drug discovery, genetics, and biochemistry. Published by Springer Heidelberg in Germany, this influential journal has established its significance within the academic community, achieving an impressive Q1 ranking across multiple categories as of 2023, including Drug Discovery, Clinical Genetics, and Molecular Medicine. With a focus on publishing high-quality research and novel insights, JMM appeals to a diverse audience of researchers, professionals, and students passionate about the molecular underpinnings of health and disease. The journal, which has seen a convergence of relevant research spanning from 1976 to 2024, is instrumental in showcasing groundbreaking studies that push the boundaries of knowledge in molecular therapeutics and biomedical science. While it does not offer open access, the rigor of its peer-reviewed content ensures that each publication is a valuable addition to the scientific discourse surrounding molecular medicine. For comprehensive studies and reviews that highlight the intersection of molecular biology and clinical application, look no further than JOURNAL OF MOLECULAR MEDICINE.
Cold Spring Harbor Molecular Case Studies
Bridging the gap between molecular research and patient care.Cold Spring Harbor Molecular Case Studies is a prestigious journal published by COLD SPRING HARBOR LAB PRESS, PUBLICATIONS DEPT, that has garnered considerable attention in the fields of Biochemistry, Genetics, and Molecular Medicine. With a focus on the intersection of molecular biology and clinical case studies, this journal serves as a key resource for researchers and practitioners seeking to explore novel insights into genetic disorders and biomedical advances. Its impact is underscored by its categorization in Q2 in various disciplines in 2023, reflecting its significance and influence within the academic community. Although currently not labeled as Open Access, Cold Spring Harbor Molecular Case Studies provides a rigorous platform for disseminating high-quality, peer-reviewed research that drives innovation and enhances understanding in these rapidly evolving fields. As a supporter of advancing scientific knowledge, this journal is essential for those dedicated to the exploration of molecular mechanisms and their clinical implications.
JCI Insight
Transforming Research into Health SolutionsJCI Insight, published by the American Society for Clinical Investigation, stands as a vital resource in the field of medicine, having achieved a prestigious Q1 rating in the 2023 category for miscellaneous medicine. With an impressive Scopus rank of 27 out of 636, placing it in the 95th percentile, this journal emphasizes the dissemination of high-quality, peer-reviewed research that pushes the boundaries of clinical and translational science. Since becoming an Open Access journal in 2020, JCI Insight has expanded its reach, providing researchers, professionals, and students around the globe with unfettered access to groundbreaking studies and reviews. The journal focuses on a wide spectrum of topics relevant to the medical community, making it an essential platform for sharing innovative findings and fostering collaboration among scientists dedicated to transforming health outcomes. Based in Ann Arbor, Michigan, JCI Insight continues to inspire advancements in medical research, contributing significantly to the ongoing dialogue in the ever-evolving healthcare landscape.
Biomed Research International
Exploring the frontiers of biomedicine for a healthier future.Biomed Research International is a prominent open access journal published by HINDAWI LTD, dedicated to advancing the field of biomedical research. With its ISSN 2314-6133 and E-ISSN 2314-6141, this journal has been a significant contributor to the scientific community since its inception in 2013, making scholarly work accessible to a global audience. The journal's scope encompasses a range of disciplines, including biochemistry, genetics, molecular biology, immunology, microbiology, and medicine, reflecting its commitment to interdisciplinary research. Ranked in the Q2 quartile as of 2023 across several relevant categories, Biomed Research International is recognized for its high-quality publications that foster innovation and collaboration in biomedical studies. Researchers, professionals, and students looking to share and gain insights into cutting-edge biomedical discoveries will find this journal an essential resource. With a focus on rapid dissemination of research findings, the journal serves as a vital platform for academics to engage with contemporary issues in health and disease, ultimately contributing to the advancement of medical science.
Circulation-Genomic and Precision Medicine
Transforming Patient Care with Precision MedicineCirculation-Genomic and Precision Medicine is a leading peer-reviewed journal published by Lippincott Williams & Wilkins, dedicated to advancing the fields of cardiology, cardiovascular medicine, and genetics. With an impressive impact factor and ranked in the Q1 quartile across multiple categories, including Cardiology and Genetics, this journal is pivotal for researchers and professionals seeking the latest insights and advancements in precision medicine. Established in 2018, it has rapidly gained recognition, evidenced by its commendable Scopus ranking and high percentiles among related fields. The journal emphasizes open access to enhance the dissemination of knowledge, making cutting-edge research readily available to a global audience. With the convergence of genomic science and cardiovascular health, Circulation-Genomic and Precision Medicine aims to foster interdisciplinary collaborations, offering a vital platform for innovative studies that impact patient care and clinical practices.
Journal of Translational Medicine
Advancing Healthcare through Translational Insights.Journal of Translational Medicine, published by BMC in the United Kingdom, stands at the forefront of biomedical research, bridging the gap between laboratory discoveries and clinical applications. Established in 2003 as an Open Access journal, it has garnered significant recognition, achieving a Q1 quartile ranking in both Biochemistry, Genetics and Molecular Biology and Medicine categories as of 2023. With an impressive Scopus rank of 38 out of 636 in General Medicine and 33 out of 221 in General Biochemistry, Genetics and Molecular Biology, the journal is committed to disseminating high-quality, peer-reviewed research that impacts healthcare and informs clinical practices. By facilitating free access to groundbreaking studies, the Journal of Translational Medicine aims to enhance collaboration among researchers, professionals, and students in the scientific community, fostering advancements in translational research well into the future.
Advanced Biomedical Research
Bridging Knowledge Gaps in Health SciencesAdvanced Biomedical Research, published by Wolters Kluwer Medknow Publications, is a prominent open access journal dedicated to advancing the field of biomedical research since its inception in 2012. With an ISSN of 2277-9175, this journal serves as a vital platform for researchers, professionals, and students to disseminate high-quality research findings and innovative ideas in a variety of topics within biochemistry, genetics, and molecular biology. Recognized within the Q3 category of the 2023 journal quartile rankings, it ranks 365th among general medicine journals and 187th in the general fields of biochemistry and genetics, underscoring its commitment to fostering scientific dialogue and collaboration. With its open access model, Advanced Biomedical Research ensures that research is readily accessible to a global audience, thereby enhancing the visibility and impact of scholarly work. As the journal continues to evolve through its converged editorial focus from 2019 to 2024, it aims to play a critical role in shaping the future of biomedical sciences in India and beyond.
CLINICAL AND EXPERIMENTAL MEDICINE
Pioneering Discoveries in Clinical and Experimental MedicineClinical and Experimental Medicine is a leading journal published by Springer-Verlag Italia SRL, dedicated to advancing the understanding of the intricate relationships between biomedical research and clinical applications. Since its inception in 2001, the journal has garnered an esteemed reputation, achieving Q1 quartile rankings in 2023 in both Biochemistry, Genetics and Molecular Biology (miscellaneous) and Medicine (miscellaneous), establishing itself as a key resource for researchers and practitioners alike. With an impactful contribution reflected in its Scopus rankings, particularly a #81/221 rank in the General Biochemistry, Genetics and Molecular Biology category, Clinical and Experimental Medicine serves as a rich platform for peer-reviewed articles that bridge theory and practice across diverse medical disciplines. The journal embraces Open Access options, broadening the accessibility of groundbreaking research to a global audience, thereby fostering collaboration and innovation. Located in Milan, Italy, it continually endeavors to enrich knowledge and share valuable insights essential for the advancement of health sciences.
Annual Review of Pathology-Mechanisms of Disease
Exploring the Frontiers of Pathological ResearchAnnual Review of Pathology: Mechanisms of Disease is a premier scholarly journal published by ANNUAL REVIEWS that systematically reviews significant advancements in the field of pathology and the mechanisms underpinning various diseases. With an ISSN of 1553-4006 and an E-ISSN of 1553-4014, the journal has established its importance within the academic community, evidenced by its prestigious Q1 rankings in several categories including medicine, pathology, forensic medicine, and plant science for 2023. Notably, it ranks #1 out of 208 in the pathology and forensic medicine category, placing it in the 99th percentile according to Scopus metrics. Although not an open-access journal, it offers crucial insights to researchers, professionals, and students alike by providing a comprehensive understanding of pathophysiological concepts and emerging trends. The journal continues to be an essential resource for those dedicated to advancing research and practical applications in disease mechanisms.
ARCHIVES OF MEDICAL RESEARCH
Exploring the frontiers of medicine, one study at a time.Archives of Medical Research is a prestigious scholarly journal dedicated to advancing the field of medicine through the dissemination of high-quality research findings. Published by Elsevier Science Inc., this esteemed journal has garnered significant recognition, boasting a remarkable impact factor and ranking in the top quartile (Q1) of its category, specifically in General Medicine with a Scopus rank of #30 out of 636 journals, placing it in the 95th percentile. Since its inception in 1992, Archives of Medical Research has served as a critical platform for researchers and professionals to share innovative insights and empirical studies that address pressing medical issues and enhance clinical practices. The journal welcomes a range of submissions, ensuring a diverse array of topics that reflect the latest trends and developments in medicine. As the journal continues to push the boundaries of medical research until at least 2025, it remains an essential resource for students, academics, and healthcare professionals striving to make a meaningful impact in the medical community.